Previous Article | Next Article ![]()
Molecular and Cellular Biology, August 2006, p. 5994-6004, Vol. 26, No. 16
0270-7306/06/$08.00+0 doi:10.1128/MCB.01630-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
,
Andrea Michael Meyer,1,4,
Christiane Wirbelauer,2
Daniel Hess,2
Ulrike Kogel,3
Martin Scheffner,3 and
Wilhelm Krek1*
Institute of Cell Biology, ETH-Hönggerberg, 8093 Zurich, Switzerland,1 Friedrich Miescher Institute, Maulbeerstrasse 66, 4058 Basel, Switzerland,2 Department of Biology, University of Konstanz, D-78457 Konstanz, Germany,3 Zurich PhD Program in Molecular Life Sciences, Zurich, Switzerland4
Received 23 August 2005/ Returned for modification 22 September 2005/ Accepted 5 June 2006
Ubiquitin-mediated degradation of the cyclin-dependent kinase inhibitor p27 provides a powerful route for enforcing normal progression through the mammalian cell cycle. According to a current model, the ubiquitination of p27 during S-phase progression is mediated by SCFSkp2 E3 ligase that captures Thr187-phosphorylated p27 by means of the F-box protein Skp2, which in turn couples the bound substrate via Skp1 to a catalytic core complex composed of Cul1 and the Rbx/Roc RING finger protein. Here we identify Skp2 as a component of an Skp1-cullin-F-box complex that is based on a Cul1-Ro52 RING finger B-box coiled-coil motif family protein catalytic core. Ro52-containing complexes display E3 ligase activity and promote the ubiquitination of Thr187-phosphorylated p27 in a RING-dependent manner in vitro. The knockdown of Ro52 expression in human cells with small interfering RNAs causes the accumulation of p27 and the failure of cells to enter S phase. Importantly, these effects are abrogated by the simultaneous removal of p27. Taken together, these data suggest a key role for Ro52 RING finger protein in the regulation of p27 degradation and S-phase progression in mammalian cells and provide evidence for the existence of a Cul1-based catalytic core that utilizes Ro52 RING protein to promote ubiquitination.
These authors contributed equally to this work.
Present address: Forschung Orthopaedie, Uniklinik Balgrist, Forchstrasse 340, 8008 Zurich, Switzerland.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»